Date Published | Source | Title/Link/Description |
1/3/24 |
CDC
| |
11/1/23 |
CDC
| |
8/22/23 |
HHS
| |
5/25/23 |
FDA
| |
5/11/23 |
HHS
| |
4/4/23 |
FDA
| |
2/7/23 |
FDA
| |
1/17/23 |
CDC
| |
1/5/23 |
NIH
| |
1/6/23 |
FDA
| |
12/28/22 |
CDC
| |
12/23/22 | FDA |
FDA Approves Actemra for Adults |
9/23/22 |
CDC
|
Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic
|
9/22/22 |
CDC
|
CDC Strategy for Global Response to COVID-19 (2020-2023)
|
9/8/22 |
White House
|
Biden Administration Outlines Plan to Get Americans an Updated COVID-19 Vaccine Shot and Manage COVID-19 this Fall
|
8/19/22 |
CDC
| |
8/2/22 |
HHS
| |
8/2/22 |
HHS
| |
8/2/22 |
HHS
| |
5/24/22 |
CDC
| |
5/24/22 |
CDC
| |
5/10/22 |
FDA
|
Approval of a new indication for Olumiant (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen
|
4/25/22 |
FDA
|
FDA Approves First COVID-19 Treatment for Young Children
|
4/14/22 |
FDA
| |
4/5/22 |
HHS, ASPR
| |
3/10/22 |
CDC
| |
1/20/22 |
CDC
|
Quarantine and Isolation Guidance
|
12/8/21 |
FDA
| |
12/2/21 |
FDA
| |
9/17/21 |
CDC
|
$2.1 Billion announced by the Biden administration to improve infection control
|
9/10/21 |
CDC
|
Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic
|
9/10/21 |
CDC
|
Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2
|
9/10/21 |
CDC
|
Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes
|
7/30/21 |
FDA
| |
7/27/21 |
CDC
| |
7/26/21 |
HHS, DOJ
| |
6/30/21 |
HHS
|
COVID-19 Monoclonal Antibody Therapeutics Calculator for Infusion Sites
|
6/24/21 |
FDA
| |
6/17/21 |
HHS
| |
6/14/21 |
CDC
|
Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance
|
5/27/21 |
HHS
| |
5/26/21 |
ASPR, FDA
|
Certain States Pause Distribution of Bamlanivimab and Estesebimab Together
|
5/14/21 |
FDA
| |
5/13/21 |
CMS
|
Updated Interim Public Health Recommendations for Fully Vaccinated People
|
5/13/21 |
CMS
| |
5/6/21 |
CMS
| |
4/27/21 |
CDC
|
Interim Public Health Recommendations for Fully Vaccinated People
|
4/27/21 |
CDC
|
Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
|
4/16/21 |
FDA
| |
4/13/21 |
NIH
| Trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins |
3/18/21 |
FDA
| Updated health care provider fact sheets – monoclonal antibody therapies |
3/17/21 |
HHS
| |
3/16/21 |
FDA
|
Screening for COVID-19: Deciding Which Test to Use When Establishing Testing Programs
|
3/10/21 | CDC |
Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
|
3/8/21 | CDC |
Interim Public Health Recommendations for Fully Vaccinated People
|
2/10/21 | CDC | |
2/9/21 | FDA | |
2/8/21 | CMS | |
1/28/21 | CDC |
Requirement for Proof of Negative COVID-19 Test or Recovery from COVID-19 for All Air Passengers Arriving in the United States
|
1/12/21 | HHS | |
1/7/21 | CDC |
New COVID-19 Variants, Variant Cases
|
11/24/20 | FDA | |
11/21/20 | FDA | |
11/19/20 | FDA | |
11/17/20 | FDA | |
11/10/20 | CMS | |
11/10/20 | Eli Lilly, FDA | |
11/10/20 | Eli Lilly | |
11/10/20 | FDA | |
11/10/20 | HHS, DoD | |
11/9/20 | FDA | |
11/9/20 | NIH | |
11/4/20 | CDC |
Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During COVID-19 Pandemic
|
11/4/20 | HHS, DoD | |
11/2/20 | HHS, DoD | |
10/29/20 | CDC |
Wear Face Masks on Public Transportation Conveyances and at Transportation Hubs
|
10/22/20 | FDA | |
10/21/20 | CDC | |
10/21/20 | CDC |
CDC updates definition of “close contact”
|
10/13/20 | NIH | |
10/6/20 | FDA | |
10/5/20 | CDC | |
10/1/20 | HHS |
Remdesivir Now Available Directly from Distributor
|
9/1/20 | FDA |
Stop Using Gowns, including Surgical Gowns, from Laws of Motion PPE – Letter to Health Care Providers
|
8/28/20 | FDA | |
8/24/20 | CDC |
Updated Guidance for SARS-CoV-2 (COVID-19) Testing
|
8/23/20 | FDA | |
8/5/20
| FDA | |
7/30/20 | FDA | |
7/30/20 | CMS, CDC | |
7/28/20 | CMS | |
7/18/20 | CDC |
How to Report COVID-19 Laboratory Data
|
7/17/20 | CDC |
Updated Interim Guidance, Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection
|
7/17/20 | CDC |
Updated Interim Guidance, Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings
|
7/17/20 | CDC |
Duration of Isolation and Precautions for Adults with COVID-19 (Decision Memo)
|
6/28/20 | CDC |
Considerations for Wearing Cloth Face Coverings
|
6/25/20 | CDC |
People Who Need Extra Precautions: People of Any Age with Underlying Medical Conditions
|
4/30/20 | CDC |
Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings
|
4/30/20 | CDC |
Updated Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19
|
4/13/20 | CDC |
Updated Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Healthcare Settings
|
4/8/20 | CDC | Updated guidance for critical infrastructure workers’ return to work following exposure to COVID-19 |
4/8/20 | CMS | Updated Infection Control Guidance for Inpatient and Outpatient Settings |
3/31/20 | FEMA | Coronavirus (COVID-19) Pandemic: Non-Congregate Sheltering |
3/30/20 | HHS | Secretary Azar Statement on FDA Authorization of Mask Sterilization Procedure |
3/29/20 | FDA | Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency |
3/29/20 | FDA | Emergency Use Authorization for the Emergency Used of the Battelle CCDS Critical Care Decontamination System |
3/26/20 | FDA | Q&A for Consumers: Hand Sanitizers and COVID-19 |
3/23/20 | CMS | CMS Announces Findings at Kirkland Nursing Home and New Targeted Plan for Healthcare Facility Inspections in Light of COVID-19 |
3/20/20 | CMS | Minimizing Face-to-Face Contact for Medication Delivery or Dispensing |
3/17/20 | CMS | Information for PACE Organizations Regarding Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) |
3/16/20 | White House | Coronavirus Guidelines for America |
3/13/20 | CMS | Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes-REVISED |
3/11/20 | FDA | Surgical Mask and Gown Conservation Strategies – Letter to Healthcare Providers |
3/10/20 | CMS | Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Dialysis Facilities |
3/10/20 | CMS | Guidance for Use of Certain Industrial Respirators by Health Care Personnel |
3/10/20 | CMS | Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs) |
3/10/20 | CMS | CMS Issues Key Protective Mask Guidance for Healthcare Workers |
3/10/20 | CMS | CMS Sends More Detailed Guidance to Providers about COVID-19 |
3/9/20 | CMS | Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) by Hospice Agencies |
3/9/20 | CMS | CMS Issues Clear, Actionable Guidance to Providers about COVID-19 Virus |
3/4/20 | CMS | Guidance for Infection Control and Prevention Concerning Coronavirus Disease (COVID-19): FAQs and Considerations for Patient Triage, Placement and Hospital Discharge |
3/4/20 | CMS | CMS Announces Actions to Address Spread of Coronavirus |